Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Syneos Health stock | $87.74

Learn how to easily invest in Syneos Health stock.

Syneos Health Inc is a diagnostics & research business based in the US. Syneos Health shares (SYNH) are listed on the NASDAQ and all prices are listed in US Dollars. Syneos Health employs 24,310 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Syneos Health

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SYNH – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Syneos Health stock price (NASDAQ: SYNH)

Use our graph to track the performance of SYNH stocks over time.

Syneos Health shares at a glance

Information last updated 2021-10-17.
Latest market close$87.74
52-week range$51.04 - $97.27
50-day moving average $91.67
200-day moving average $87.43
Wall St. target price$102.00
PE ratio 39.1388
Dividend yield N/A (0%)
Earnings per share (TTM) $2.24

Buy Syneos Health shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Syneos Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Syneos Health price performance over time

Historical closes compared with the close of $87.74 from 2021-10-20

1 week (2021-10-15) 0.03%
1 month (2021-09-22) -7.91%
3 months (2021-07-22) -0.41%
6 months (2021-04-22) -1.08%
1 year (2020-10-22) 50.65%
2 years (2019-10-22) 61.08%
3 years (2018-10-22) 90.49%
5 years (2016-10-21) 85.11%

Is Syneos Health under- or over-valued?

Valuing Syneos Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Syneos Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Syneos Health's P/E ratio

Syneos Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 39x. In other words, Syneos Health shares trade at around 39x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Syneos Health's PEG ratio

Syneos Health's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.1674. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Syneos Health's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Syneos Health's EBITDA

Syneos Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $633.7 million.

The EBITDA is a measure of a Syneos Health's overall financial performance and is widely used to measure a its profitability.

Syneos Health financials

Revenue TTM $4.7 billion
Operating margin TTM 8.62%
Gross profit TTM $1 billion
Return on assets TTM 3.31%
Return on equity TTM 7.56%
Profit margin 4.99%
Book value $31.30
Market capitalisation $9.1 billion

TTM: trailing 12 months

Shorting Syneos Health shares

There are currently 2.2 million Syneos Health shares held short by investors – that's known as Syneos Health's "short interest". This figure is 0.8% up from 2.1 million last month.

There are a few different ways that this level of interest in shorting Syneos Health shares can be evaluated.

Syneos Health's "short interest ratio" (SIR)

Syneos Health's "short interest ratio" (SIR) is the quantity of Syneos Health shares currently shorted divided by the average quantity of Syneos Health shares traded daily (recently around 566163.25459318). Syneos Health's SIR currently stands at 3.81. In other words for every 100,000 Syneos Health shares traded daily on the market, roughly 3810 shares are currently held short.

However Syneos Health's short interest can also be evaluated against the total number of Syneos Health shares, or, against the total number of tradable Syneos Health shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Syneos Health's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Syneos Health shares in existence, roughly 20 shares are currently held short) or 0.0209% of the tradable shares (for every 100,000 tradable Syneos Health shares, roughly 21 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Syneos Health.

Find out more about how you can short Syneos Health stock.

Syneos Health share dividends

We're not expecting Syneos Health to pay a dividend over the next 12 months.

Syneos Health share price volatility

Over the last 12 months, Syneos Health's shares have ranged in value from as little as $51.04 up to $97.27. A popular way to gauge a stock's volatility is its "beta".

SYNH.US volatility(beta: 1.79)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Syneos Health's is 1.7868. This would suggest that Syneos Health's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Syneos Health overview

Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers various services spanning Phases I to IV of clinical development, including full service global studies, as well as individual service offerings, such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with their drug development process. The Commercial Solutions segment provides commercialization services comprising deployment solutions; communications solutions, such as public relations, advertising, and medical communications; and consulting services. Its customers include small, mid-sized, and large companies in the pharmaceutical, biotechnology, and medical device industries. Syneos Health, Inc.

Frequently asked questions

What percentage of Syneos Health is owned by insiders or institutions?
Currently 0.242% of Syneos Health shares are held by insiders and 101.039% by institutions.
How many people work for Syneos Health?
Latest data suggests 24,310 work at Syneos Health.
When does the fiscal year end for Syneos Health?
Syneos Health's fiscal year ends in December.
Where is Syneos Health based?
Syneos Health's address is: 1030 Sync Street, Morrisville, NC, United States, 27560-5468
What is Syneos Health's ISIN number?
Syneos Health's international securities identification number is: US87166B1026
What is Syneos Health's CUSIP number?
Syneos Health's Committee on Uniform Securities Identification Procedures number is: 45329R109

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site